Publication: Real-life report of allergen immunotherapy management during the COVID-19 outbreak in France and Spain.
Loading...
Identifiers
Date
2021-11-04
Authors
Rodriguez Del Rio, Pablo
Caimmi, Davide
Rico, Pilar
Vidal, Carmen
Carmen, Moreno
Pintoiu, Ileana M
Beitia Mazuecos, Jose M
Gonzalez de Olano, David
Cuesta Alvaro, Pedro
Demoly, Pascal
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Metrics
Export
Abstract
The COVID-19 pandemic represents a global health crisis and a challenge at all societal, economic and health levels. With the first cases having been reported in most of the European countries in January 2020,1 it was not until March that the pandemic hit the territory and lead to an unprecedent hard lock-down in most countries.
Description
MeSH Terms
Humans
Hypersensitivity
Practice patterns, physicians'
Quarantine
SARS-CoV-2
Spain
Hypersensitivity
Practice patterns, physicians'
Quarantine
SARS-CoV-2
Spain
DeCS Terms
Cuarentena
España
Hipersensibilidad
Pautas de la práctica en medicina
España
Hipersensibilidad
Pautas de la práctica en medicina
CIE Terms
Keywords
Anti-allergic agents, COVID-19, Desensitization, immunologic, France
Citation
Rodriguez Del Rio P, Caimmi D, Rico P, Vidal C, Carmen M, Pintoiu IM, et al. Real-life report of allergen immunotherapy management during the COVID-19 outbreak in France and Spain. Clin Exp Allergy. 2022 Jan;52(1):167-170